It takes a village to care for patients with obstetric fistula—a serious childbirth injury caused by prolonged, obstructed labor without access to timely emergency care. These Kenyan nurses are doing more than delivering treatment—they’re helping women heal physically, emotionally and socially through comprehensive care. Nurses are leaders, innovators, advocates and so much more in communities around the world. Learn more about J&J CareCommunity and how we proudly support nurses like these as they connect their communities to care: https://lnkd.in/dN6RVfqh
About us
At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
- Website
-
http://www.jnj.com
External link for Johnson & Johnson
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- New Brunswick, NJ
- Type
- Public Company
- Specialties
- Health Care, Medical Devices & Diagnostics, and Pharmaceuticals
Locations
Employees at Johnson & Johnson
Updates
-
We will be sharing our latest data in blood cancers and solid tumors at the American Society of Clinical Oncology (ASCO) annual meeting and European Hematology Association (EHA) congress as part of our continued efforts to get #InFrontofCancer.
At Johnson & Johnson, we're driven by our bold vision for a future where people with cancer have more options and more time. At this year’s American Society of Clinical Oncology (ASCO) annual meeting and European Hematology Association (EHA) congress, we’ll be sharing data from more than 70 abstracts across our solid tumor and hematology portfolio and pipeline. See how we’re getting #InFrontofCancer: https://lnkd.in/dAAFQwXK #JNJOncology #ASCO25 #EHA2025
-
Innovation never stops—so why should learning? From VR training to hands-on education, see how we’re empowering physicians around the world to stay ahead and provide the best care possible: https://lnkd.in/eB3W324e
-
We’re redefining life for patients with cancers like multiple myeloma. Explore what our integrated oncology teams are working on: https://lnkd.in/eXwEgxWP
-
Did you know lifestyle changes can lower your odds of developing colorectal cancer? Swipe to explore the key facts to know, and how we’re treating it with the latest innovations: https://lnkd.in/gftrMuQh
-
The U.S. FDA has approved our immunoselective treatment for people living with generalized myasthenia gravis (gMG). This treatment option may help people with gMG achieve lasting disease control. Discover how this approval builds on our decades of leadership in immunology and neuroscience: https://lnkd.in/eSEGrxex
-
How do you build an environment where nurses feel empowered to shape their work? Discover how this team’s nursing innovation units helped transform care delivery, improve job satisfaction and strengthen recruitment efforts: https://lnkd.in/e7i4jkgM #NursesMonth
-
-
Today, we’re proud to announce our flagship nursing programs through J&J CareCommunity, a social impact platform that aims to support nurses at every step of their career journey and strengthen health systems. See how flagship programs are helping elevate, empower and equip nurses worldwide: https://lnkd.in/eaz8tVFi #NursesMonth
-
From cardiology to cancer, mental health to vision, cell therapies to robotics, the depth and breadth of our expertise and capabilities are unmatched. We have incredible opportunities to improve patients’ lives, advance the standard of care, and drive growth. Our Chairman and CEO Joaquin Duato discussed how we are transforming the future of healthcare at our Annual Shareholder Meeting.
Tackling the world’s toughest health challenges as Chairman and Chief Executive Officer of Johnson & Johnson
Johnson & Johnson’s portfolio and pipeline have never been stronger. At our Annual Shareholder Meeting I celebrated the progress we made over the last year while showcasing some of the incredible opportunities ahead of us to improve patients’ lives. We could not achieve any of this without our most important source of innovation—our more than 138,000 employees who bring their commitment to patients with them to work every day. We are transforming health for humanity. There’s no team like Team J&J! You can find more information about our Annual Shareholder Meeting here: https://lnkd.in/e7St6wEu
-
Melissa, a nurse turned clinical scientist in our Interventional Oncology R&D group, is developing lifesaving cancer therapies and redefining nursing's role in research. With a focus on accessibility in clinical trials, she’s paving the way for more effective treatments. Discover how her journey is transforming healthcare: https://lnkd.in/dsY6fmZP
-
Affiliated pages
Similar pages
Browse jobs
Stock
JNJ
NYSE
20 minutes delay
$152.94
0.33 (0.216%)
- Open
- 153
- Low
- 152.21
- High
- 153.48
Data from Refinitiv
See more info on